• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc. - Common Stock (NQ:POAI)

0.7962 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7962
Bid (Size) 0.7399 (1)
Ask (Size) 0.8200 (1)
Prev. Close 0.7962
Today's Range 0.7962 - 0.7962
52wk Range 0.5500 - 3.060
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
July 15, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
July 08, 2025
From Predictive Oncology Inc.
Via GlobeNewswire

Performance

YTD
-13.5%
-13.5%
1 Month
-6.9%
-6.9%
3 Month
-16.8%
-16.8%
6 Month
-46.2%
-46.2%
1 Year
-29.5%
-29.5%

More News

Read More
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
June 12, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Court Denies Renovaro Motion for an Expedited Trial in July
May 27, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish
May 22, 2025
Via Stocktwits
Topics Artificial Intelligence Lawsuit
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025
From Renovaro Inc
Via GlobeNewswire
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025
From Renovaro Inc
Via GlobeNewswire
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
May 22, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
May 20, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 15, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
May 12, 2025
Via FinancialNewsMedia
Topics Artificial Intelligence
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
May 12, 2025
From FN Media Group LLC
Via GlobeNewswire
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
April 15, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
Via FinancialNewsMedia
Topics Artificial Intelligence
12 Health Care Stocks Moving In Friday's After-Market Session
April 04, 2025
Via Benzinga
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
From FN Media Group LLC
Via GlobeNewswire
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 04, 2025
From Renovaro Inc
Via GlobeNewswire
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
April 01, 2025
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 26, 2025
Via Benzinga
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
March 25, 2025
Via AB Newswire
Topics Artificial Intelligence
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
March 25, 2025
Via Chartmill
Discover the most active stocks in Tuesday's session.
March 25, 2025
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
March 25, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 25, 2025
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
March 25, 2025
Via Chartmill

Frequently Asked Questions

Is Predictive Oncology Inc. - Common Stock publicly traded?
Yes, Predictive Oncology Inc. - Common Stock is publicly traded.
What exchange does Predictive Oncology Inc. - Common Stock trade on?
Predictive Oncology Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Predictive Oncology Inc. - Common Stock?
The ticker symbol for Predictive Oncology Inc. - Common Stock is POAI on the Nasdaq Stock Market
What is the current price of Predictive Oncology Inc. - Common Stock?
The current price of Predictive Oncology Inc. - Common Stock is 0.7962
When was Predictive Oncology Inc. - Common Stock last traded?
The last trade of Predictive Oncology Inc. - Common Stock was at 07/23/25 04:00 PM ET
What is the market capitalization of Predictive Oncology Inc. - Common Stock?
The market capitalization of Predictive Oncology Inc. - Common Stock is 3.24M
How many shares of Predictive Oncology Inc. - Common Stock are outstanding?
Predictive Oncology Inc. - Common Stock has 3M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap